Dejana Braithwaite, PhD, MSc,
Professor and Division Chief, Population Health Sciences, Department of Surgery
Department:
MD-SURG-POPULATION HEALTH SCI
Business Phone:
(352) 294-5822
Business Email:
dbraithwaite@ufl.edu
About Dejana Braithwaite, PhD, MSc
Additional Positions:
Division Chief, Population Health Sciences
2024 – Current
·
Department of Surgery
Associate Director for Cancer Population Sciences
2020 – Current
·
UF Health Cancer Center
Accomplishments
Inductee
2017
·
Royal Society of Medicine (UK)
Member, Expert Panel
2015
·
National Academy of Sciences, Institute of Medicine, National Cancer Policy Forum
Mentored Research Scholar Award
2012-2017
·
American Cancer Society
Career Catalyst Award
2011-2014
·
Susan Komen Foundation
Junior Investigator Award
2011
·
National Center of Excellence in Women’s Health, University of California, San Francisco
Junior Investigator Award
2010
·
Academic Senate, University of California, San Francisco
Developmental Award
2009
·
NIH Bay Area Breast Cancer Specialized Program of Research Excellence (SPORE)
Hellman Foundation Award for Early Career Faculty
2009
·
University of California, San Francisco
Cancer Prevention Research Fellowship (1 awarded nationally in the United States)
2007
·
Prevent Cancer Foundation/American Society for Preventive Oncology
Scholar-in-Training Award
2003
·
American Association for Cancer Research, Frontiers in Cancer Prevention
Pre-doctoral Fellowship (2 awarded nationally in the United Kingdom)
2000
·
Cancer Research U.K.
Teaching Profile
Courses Taught
2022-2025
PHC7918 Independent Study
2022-2025
PHC7979 Advanced Research
2023
PHC7916 National Field Epidemiology
2024
PHC7980 Research for Doctoral Dissertation
2024
PHC6001 Principles of Epidemiology in Public Health
2025
PHC6937 Special Topics in Public Health
Research Profile
Dr. Braithwaite currently leads the Division of Population Health Sciences in the College of Medicine at the University of Florida (UF), and serves as Associate Director for Population Sciences at the UF Health Cancer Center. With an interdisciplinary background in epidemiology, health services research, cancer control and biomedical informatics, Dr. Braithwaite’s work is targeted at developing the evidence to guide healthcare policy decisions and innovative interventions to reduce the burden of cancer and other chronic diseases. Her research program has received awards from the American Cancer Society, American Society for Preventive Oncology and the Prevent Cancer Foundation. Dr. Braithwaite has extensive leadership experience in team science, including leading large, complex, multi-site, multi-project grants. Using diverse data sources and AI technology, Dr. Braithwaite’s team focuses on effectively monitoring, assessing and applying innovative methods to advance healthcare. In addition, Dr. Braithwaite’s research places emphasis on addressing digital inclusion while ensuring that diverse populations receive access to healthcare and resources.
Open Researcher and Contributor ID (ORCID)
0000-0001-8376-5903
Publications
Academic Articles
2025
Evaluating the Effectiveness of ChatGPT and Google Gemini in Providing Lung Cancer Screening Recommendations for Vulnerable Communities
CHEST Pulmonary.
[DOI] 10.1016/j.chpulm.2025.100167.
2025
Participation in Non-small Cell Lung Cancer Clinical Trials in the United States by Race/Ethnicity
Clinical Lung Cancer.
26(1):52-57.e2
[DOI] 10.1016/j.cllc.2024.09.009.
2025
Toward a Computable Phenotype for Determining Eligibility of Lung Cancer Screening Using Electronic Health Records
JCO Clinical Cancer Informatics.
(9)
[DOI] 10.1200/cci.24.00139.
2024
Association of Physical Frailty and Cognitive Function in a Population-Based Cross-Sectional Study of American Older Adults.
Gerontology.
70(1):48-58
[DOI] 10.1159/000533919.
[PMID] 37903474.
2024
Associations between Plasma Tocopherols and Lung Cancer Risk: Results from the Southern Community Cohort Study
Cancer Epidemiology, Biomarkers & Prevention.
33(4):480-488
[DOI] 10.1158/1055-9965.epi-23-1107.
2024
Disparities in Utilization of Immune Checkpoint Inhibitor Therapy Among Older Patients With Advanced Non–Small Cell Lung Cancer: A SEER-Medicare Analysis
JCO Oncology Advances.
(1)
[DOI] 10.1200/oa.24.00008.
2024
Evaluating ChatGPT’s accuracy in providing screening mammography recommendations among older women: Artificial Intelligence and cancer communication.
Journal of the American Geriatrics Society.
72(7):2237-2240
[DOI] 10.1111/jgs.18854.
[PMID] 38485652.
2024
Evaluating ChatGPT’s Accuracy in Providing Screening Mammography Recommendations among Older Women: Artificial Intelligence and Cancer Communication.
Research square.
[DOI] 10.21203/rs.3.rs-3911155/v1.
[PMID] 38352437.
2024
Extracting Pulmonary Nodules and Nodule Characteristics from Radiology Reports of Lung Cancer Screening Patients Using Transformer Models.
Journal of healthcare informatics research.
8(3):463-477
[DOI] 10.1007/s41666-024-00166-5.
[PMID] 39131104.
2024
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
Lancet (London, England).
403(10440):1989-2056
[DOI] 10.1016/S0140-6736(24)00476-8.
[PMID] 38484753.
2024
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet (London, England).
403(10440):2162-2203
[DOI] 10.1016/S0140-6736(24)00933-4.
[PMID] 38762324.
2024
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet (London, England).
403(10440):2100-2132
[DOI] 10.1016/S0140-6736(24)00367-2.
[PMID] 38582094.
2024
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
Lancet (London, England).
403(10440):2057-2099
[DOI] 10.1016/S0140-6736(24)00550-6.
[PMID] 38521087.
2024
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet (London, England).
403(10440):2133-2161
[DOI] 10.1016/S0140-6736(24)00757-8.
[PMID] 38642570.
2024
Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
The Lancet. Neurology.
23(4):344-381
[DOI] 10.1016/S1474-4422(24)00038-3.
[PMID] 38493795.
2024
Household Income Is Associated with Chronic Pain and High-Impact Chronic Pain among Cancer Survivors: A Cross-Sectional Study Using NHIS Data
Cancers.
16(16)
[DOI] 10.3390/cancers16162847.
[PMID] 39199618.
2024
Iron and cancer: overview of the evidence from population-based studies.
Frontiers in oncology.
14
[DOI] 10.3389/fonc.2024.1393195.
[PMID] 39246326.
2024
Patient-Provider Discussion About Lung Cancer Screening by Race and Ethnicity: Implications for Equitable Uptake of Lung Cancer Screening.
Clinical lung cancer.
25(1):39-49
[DOI] 10.1016/j.cllc.2023.08.013.
[PMID] 37673782.
2024
Persistent poverty disparities in incidence and outcomes among oral and pharynx cancer patients.
Cancer causes & control : CCC.
35(7):1063-1073
[DOI] 10.1007/s10552-024-01867-3.
[PMID] 38520565.
2024
Racial and socioeconomic disparities in survival among women with advanced-stage ovarian cancer who received systemic therapy.
Cancer causes & control : CCC.
35(3):487-496
[DOI] 10.1007/s10552-023-01810-y.
[PMID] 37874478.
2024
Real-World Effectiveness of Lung Cancer Screening Using Deep Learning-Based Counterfactual Prediction.
Studies in health technology and informatics.
310:419-423
[DOI] 10.3233/SHTI230999.
[PMID] 38269837.
2024
Sociodemographic and Clinical Characteristics Associated with Genetic Testing among Cancer Survivors: Evidence from Three Cancer Registries.
Public health genomics.
27(1):124-135
[DOI] 10.1159/000540341.
[PMID] 39102787.
2024
The Use of Chatbots in Head and Neck Mucosal Malignancy Treatment Recommendations.
Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
171(4):1062-1068
[DOI] 10.1002/ohn.818.
[PMID] 38769872.
2023
Allostatic load and risk of all-cause, cancer-specific, and cardiovascular mortality in older cancer survivors: an analysis of the National Health and Nutrition Examination Survey 1999-2010.
Aging and cancer.
4(2):74-84
[DOI] 10.1002/aac2.12064.
[PMID] 37576467.
2023
Association of air pollution with postmenopausal breast cancer risk in UK Biobank.
Breast cancer research : BCR.
25(1)
[DOI] 10.1186/s13058-023-01681-w.
[PMID] 37443054.
2023
Associations of Total Body Fat Mass and Skeletal Muscle Index with All-Cause and Cancer-Specific Mortality in Cancer Survivors
Cancers.
15(4)
[DOI] 10.3390/cancers15041081.
[PMID] 36831420.
2023
Beyond the AJR: Should Imaging-Based Risk Assessment Tools Be Used in Lung Cancer Screening?
AJR. American journal of roentgenology.
221(3)
[DOI] 10.2214/AJR.23.29060.
[PMID] 36722762.
2023
Cancer incidence after asthma diagnosis: Evidence from a large clinical research network in the United States.
Cancer medicine.
12(10):11871-11877
[DOI] 10.1002/cam4.5875.
[PMID] 36999938.
2023
Creating Opportunities to Eliminate Disparities in Lung Cancer Outcomes: A Call for Diverse Study Populations. Comment on Kohan et al. Disparity and Diversity in NSCLC Imaging and Genomics: Evaluation of a Mature, Multicenter Database. Cancers 2023, 15, 2096.
Cancers.
15(15)
[DOI] 10.3390/cancers15153762.
[PMID] 37568577.
2023
Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019.
EClinicalMedicine.
59
[DOI] 10.1016/j.eclinm.2023.101936.
[PMID] 37229504.
2023
Racial and ethnic inequities of palliative care use among advanced Non-Small cell lung cancer patients in the US.
Cancer medicine.
12(7):8567-8580
[DOI] 10.1002/cam4.5538.
[PMID] 36533434.
2023
Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database.
Scientific reports.
13(1)
[DOI] 10.1038/s41598-023-35216-2.
[PMID] 37210410.
2023
Survival Differences by Comorbidity Burden among Patients with Stage I/II Non-Small-Cell Lung Cancer after Thoracoscopic Resection
Cancers.
15(7)
[DOI] 10.3390/cancers15072075.
[PMID] 37046735.
2023
The Intersectionality between Race, Ethnicity, and Residential-Level Socioeconomic Status in Disparities of Head and Neck Cancer Outcomes: A SEER Study
Cancer Epidemiology, Biomarkers & Prevention.
32(4):516-523
[DOI] 10.1158/1055-9965.epi-22-1167.
2023
Trends and factors associated with secondhand smoke exposure among US cancer survivors, 2013-2020.
Cancer.
129(19):3053-3063
[DOI] 10.1002/cncr.34891.
[PMID] 37254857.
2022
Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer’s-type neuropathology.
Brain : a journal of neurology.
145(7):2518-2527
[DOI] 10.1093/brain/awac035.
[PMID] 35094057.
2022
Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis.
Annals of internal medicine.
175(1):11-19
[DOI] 10.7326/M20-8076.
[PMID] 34807717.
2022
Mammography adherence in relation to function-related indicators in older women.
Preventive medicine.
154
[DOI] 10.1016/j.ypmed.2021.106869.
[PMID] 34762965.
2022
Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study
BMJ Open.
12(6)
[DOI] 10.1136/bmjopen-2022-064142.
[PMID] 35732383.
2022
Racial Differences in Survival Among Advanced-stage Non-small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB)
Journal of Immunotherapy.
45(2):132-137
[DOI] 10.1097/CJI.0000000000000400.
2022
Simulating Colorectal Cancer Trials Using Real-World Data
JCO Clinical Cancer Informatics.
(6)
[DOI] 10.1200/cci.21.00195.
2021
Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis.
Cancers.
13(23)
[DOI] 10.3390/cancers13236109.
[PMID] 34885219.
2021
Comorbidity Profiles and Lung Cancer Screening among Older Adults: U.S. Behavioral Risk Factor Surveillance System 2017-2019.
Annals of the American Thoracic Society.
18(11):1886-1893
[DOI] 10.1513/AnnalsATS.202010-1276OC.
[PMID] 33939595.
2021
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019 a systematic analysis for the Global Burden of Disease Study 2019
Lancet Respiratory Medicine.
9(9):1030-1049
[DOI] 10.1016/S2213-2600(21)00164-8.
2021
Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities.
Journal of immunotherapy (Hagerstown, Md. : 1997).
44(5):198-203
[DOI] 10.1097/CJI.0000000000000366.
[PMID] 33758148.
2021
Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions
Journal Of Managed Care & Specialty Pharmacy.
S24-S31
[DOI] 10.18553/jmcp.2021.27.9-a.s24.
[PMID] 34534006.
2021
Inflammation in Relation to Sarcopenia and Sarcopenic Obesity among Older Adults Living with Chronic Comorbidities: Results from the National Health and Nutrition Examination Survey 1999-2006.
Nutrients.
13(11)
[DOI] 10.3390/nu13113957.
[PMID] 34836213.
2021
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
Lancet.
398(10299):503-521
[DOI] 10.1016/S0140-6736(21)00984-3.
2021
Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
The Lancet. Public health.
[DOI] 10.1016/S2468-2667(21)00065-7.
[PMID] 34051920.
2021
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
Lancet (London, England).
[DOI] 10.1016/S0140-6736(21)01169-7.
[PMID] 34051883.
2021
Type 2 Diabetes and association with neuropathological changes and domain specific cognitive decline
Alzheimers & Dementia.
[DOI] 10.1002/alz.058476.
[PMID] 34971132.
2020
Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.
Nature medicine.
26(8)
[DOI] 10.1038/s41591-020-0972-7.
[PMID] 32616917.
2020
Five insights from the Global Burden of Disease Study 2019.
Lancet (London, England).
396(10258):1135-1159
[DOI] 10.1016/S0140-6736(20)31404-5.
[PMID] 33069324.
2020
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
Lancet (London, England).
396(10258):1160-1203
[DOI] 10.1016/S0140-6736(20)30977-6.
[PMID] 33069325.
2020
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Lancet (London, England).
396(10258):1223-1249
[DOI] 10.1016/S0140-6736(20)30752-2.
[PMID] 33069327.
2020
Is education or income associated with insufficient fruit and vegetable intake among cancer survivors? A cross-sectional analysis of 2017 BRFSS data.
BMJ open.
10(12)
[DOI] 10.1136/bmjopen-2020-041285.
[PMID] 33262193.
2020
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.
Nature medicine.
26(5):750-759
[DOI] 10.1038/s41591-020-0807-6.
[PMID] 32313249.
2020
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
The lancet. Gastroenterology & hepatology.
5(1):42-54
[DOI] 10.1016/S2468-1253(19)30328-0.
[PMID] 31648970.
1983
[Solitary aneurysm of the pulmonary artery in infectious endocarditis. A case report].
Arquivos brasileiros de cardiologia.
40(3):205-7
[PMID] 6689121.
Grants
Sep 2023
ACTIVE
Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments
Role: Co-Investigator
Funding: UNIV OF MIAMI
via NATL INST OF HLTH NCI
Jul 2023
ACTIVE
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
Role: Principal Investigator
Funding: NATL INST OF HLTH NCI
Jun 2023
ACTIVE
UF Health Cancer Center Support Grant
Role: Other
Funding: NATL INST OF HLTH NCI
Sep 2022
ACTIVE
UF HEALTH CANCER CENTER PILOT PROJECTS GRANTS FUNDED THROUGHTHE FLORIDA CONSORTIUM OF NATIONAL CANCER INSTITUTE CENTER
Role: Project Manager
Funding: UF HEALTH SHANDS HOSPITAL
Jul 2022
– Jun 2023
Risk of adverse cardiovascular events in breast cancer patients receiving systemic adjuvant therapy: impact of comorbidity burden
Role: Principal Investigator
Funding: FL BREAST CANCER FOU
Jun 2022
ACTIVE
University of Florida Claude D. Pepper Older Americans Independence Center
Role: Project Manager
Funding: NATL INST OF HLTH NIA
Sep 2021
– Dec 2022
Comorbidity and Screening Outcomes Among Older Women Undergoing Mammography
Role: Principal Investigator
Funding: NATL INST OF HLTH NCI
Jun 2021
ACTIVE
Personalized screening for lung cancer: the importance of co-existing chronic conditions to clinical practice and policy
Role: Principal Investigator
Funding: NATL INST OF HLTH NCI
Jan 2020
– Dec 2024
The benefits and harms of lung cancer screening in Florida
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI
Education
Fellow, Epidemiology and Public Health
2017-2021
·
Royal Society of Medicine
Cancer Prevention Fellow
2006-2008
·
American Society of Preventive Oncology/Prevent Cancer Foundation
Postdoctoral Fellow, Center for Health and Community
2006-2007
·
University of California, San Francisco
Postdoctoral Fellow in Cancer Epidemiology
2004-2007
·
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Postdoctoral Fellow in Health Services Research, Institute for Health Policy Studies
2004-2006
·
University of California, San Francisco
Fellow in Health Outcomes Research
2000-2004
·
Institute of Public Health, University of Cambridge, England and Cancer Research
Ph.D., Epidemiology
2000-2004
·
University of Cambridge, Institute of Public Health, Faculty of Clinical Medicine, England
M.Sc. (high honors), Public Health
1998-1999
·
University College London/Kings College, England
B.Sc. (high honors), Psychology and Psychobiology
1995-1998
·
London Guildhall University, England
Contact Details
Phones:
- Business:
- (352) 294-5822
Emails:
- Business:
- dbraithwaite@ufl.edu
Addresses:
- Business Mailing:
-
PO BOX 103633
GAINESVILLE FL 32610
